BDSA is highlighting the potential impact and revenues for the five states that on Nov. 5 passed ballot measures or initiatives permitting the possession of cannabis by adults.

BDSA expects regulated cannabis legalization, including hemp cannabidiol (hCBD), to accelerate in 2021.

The disruptive COVID-19 pandemic has wreaked havoc on the U.S. retail market. Nevertheless, cannabis has persevered. Most U.S. states with a legal cannabis industry—medical or recreational—quickly deemed cannabis retailers essential businesses, allowing them to operate during even the darkest days of the pandemic.

Cresco Labs has developed a comprehensive advertising and marketing code with guiding principles to ensure that the company always markets and promotes its brands and products responsibly.

Klutch Cannabis, one of Ohio's Level 1 Medical Marijuana Cultivators and Processors, has entered a partnership with Kiva Confections to bring Kiva's cannabis confections to Ohio.

Cansortium Inc. has received approval from the Florida Department of Health and will commence sales of edibles in each of its Fluent dispensaries in the state.

BDSA has expanded its cannabis retail sales tracking coverage to include Canada, the world’s largest nationally legal cannabis market.

Global cannabis sales for 2020 will reach $19.7 billion, an increase of 38 percent over 2019 sales of $14.8 billion — even reflecting the impact of the COVID-19 pandemic — according to updated market forecasts published by BDSA (formerly BDS Analytics).

Jessica Lukas, senior VP of commercial development, BDSA, and Carl Edstrom, senior VP and principal, Survey Solutions, IRI, presented research on sales of cannabis products, consumer demographics, consumption occasions and the impact of COVID-19 during Cannabis Products Exchange, held virtually July 30-31.